Semtech R&D increased by 12.4% to $57.57M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.1%, from $47.53M to $57.57M. Over 4 years (FY 2022 to FY 2026), R&D shows an upward trend with a 7.3% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.79M | $35.50M | $37.35M | $38.29M | $38.79M | $40.60M | $35.06M | $52.50M | $50.60M | $47.43M | $46.91M | $41.51M | $41.60M | $40.08M | $42.56M | $46.66M | $47.53M | $48.20M | $49.40M | $51.22M | $57.57M |
| QoQ Change | — | -3.5% | +5.2% | +2.5% | +1.3% | +4.7% | -13.7% | +49.8% | -3.6% | -6.3% | -1.1% | -11.5% | +0.2% | -3.7% | +6.2% | +9.6% | +1.9% | +1.4% | +2.5% | +3.7% | +12.4% |
| YoY Change | — | — | — | — | +5.4% | +14.4% | -6.1% | +37.1% | +30.5% | +16.8% | +33.8% | -20.9% | -17.8% | -15.5% | -9.3% | +12.4% | +14.2% | +20.2% | +16.1% | +9.8% | +21.1% |